| Cannabinoids Δ9-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-κB and interferon-β/STAT proinflammatory pathways in BV-2 … E Kozela, M Pietr, A Juknat, N Rimmerman, R Levy, Z Vogel Journal of biological chemistry 285 (3), 1616-1626, 2010 | 311 | 2010 |
| Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis‐like disease in C57BL/6 mice E Kozela, N Lev, N Kaushansky, R Eilam, N Rimmerman, R Levy, ... British journal of pharmacology 163 (7), 1507-1519, 2011 | 222 | 2011 |
| Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death N Rimmerman, D Ben-Hail, Z Porat, A Juknat, E Kozela, MP Daniels, ... Cell death & disease 4 (12), e949-e949, 2013 | 179 | 2013 |
| Differential changes in GPR55 during microglial cell activation M Pietr, E Kozela, R Levy, N Rimmerman, YH Lin, N Stella, Z Vogel, ... FEBS letters 583 (12), 2071-2076, 2009 | 156 | 2009 |
| Cannabinoids decrease the th17 inflammatory autoimmune phenotype E Kozela, A Juknat, N Kaushansky, N Rimmerman, A Ben-Nun, Z Vogel Journal of Neuroimmune Pharmacology 8, 1265-1276, 2013 | 137 | 2013 |
| Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells A Juknat, M Pietr, E Kozela, N Rimmerman, R Levy, F Gao, G Coppola, ... PloS one 8 (4), e61462, 2013 | 127 | 2013 |
| Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells E Kozela, A Juknat, F Gao, N Kaushansky, G Coppola, Z Vogel Journal of neuroinflammation 13, 1-19, 2016 | 97 | 2016 |
| Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9‐tetrahydrocannabinol in BV‐2 microglial cells A Juknat, M Pietr, E Kozela, N Rimmerman, R Levy, G Coppola, ... British journal of pharmacology 165 (8), 2512-2528, 2012 | 94 | 2012 |
| Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice E Kozela, A Pilc, P Popik Psychopharmacology 165, 245-251, 2003 | 86 | 2003 |
| Nicotine and nicotinic receptor antagonists potentiate the antidepressant‐like effects of imipramine and citalopram P Popik, E Kozela, M Krawczyk British journal of pharmacology 139 (6), 1196-1202, 2003 | 84 | 2003 |
| Modulation of astrocyte activity by cannabidiol, a nonpsychoactive cannabinoid E Kozela, A Juknat, Z Vogel International journal of molecular sciences 18 (8), 1669, 2017 | 76 | 2017 |
| miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia—Effect of cannabinoids A Juknat, F Gao, G Coppola, Z Vogel, E Kozela PloS one 14 (2), e0212039, 2019 | 68 | 2019 |
| Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice P Popik, E Kozela, W Danysz Naunyn-Schmiedeberg's archives of pharmacology 361, 425-432, 2000 | 66 | 2000 |
| Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells E Kozela, A Juknat, N Kaushansky, A Ben-Nun, G Coppola, Z Vogel Journal of neuroinflammation 12, 1-16, 2015 | 58 | 2015 |
| Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice P Popik, E Kozela, A Pilc British journal of pharmacology 130 (6), 1425-1431, 2000 | 54 | 2000 |
| Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats E Kozela, W Danysz, P Popik European journal of pharmacology 423 (1), 17-26, 2001 | 53 | 2001 |
| Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA P Popik, E Kozela, M Wróbel, KM Wozniak, BS Slusher Neuropsychopharmacology 28 (3), 457-467, 2003 | 49 | 2003 |
| Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol–studies in BV-2 microglia and encephalitogenic T cells A Juknat, E Kozela, N Kaushansky, R Mechoulam, Z Vogel Journal of Basic and Clinical Physiology and Pharmacology 27 (3), 289-296, 2016 | 44 | 2016 |
| The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells N Rimmerman, A Juknat, E Kozela, R Levy, HB Bradshaw, Z Vogel Cellular and molecular neurobiology 31, 921-930, 2011 | 39 | 2011 |
| Cannabidiol improves cognitive impairment and reverses cortical transcriptional changes induced by ketamine, in schizophrenia-like model in rats E Kozela, M Krawczyk, T Kos, A Juknat, Z Vogel, P Popik Molecular Neurobiology 57, 1733-1747, 2020 | 38 | 2020 |
